The Food and Drug Administration, urged by Congress, has already taken a harder line on 510(k)s. Which makes it only a matter of time before the agency, wary of another Sprint Fidelis debacle, sets its sights on PMA supplements.
[Read more of this report]
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Dr. John D. HalamkaChief Medical Information Officer’s role becoming more important
Amy SiegelHow low can you go? Creating value with cheap medical devices
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Lisa Suennen2012 JP Morgan Healthcare’s (wo)men’s club is changing in a good way
Joe HageA huge American opportunity waiting to happen
Doug MowenMed tech consolidation brings a need for focus. Here are 2 ways to get it
